Goldenwell Biotech (GWLL) Other Gross PP&E Adjustments (2021 - 2024)
Goldenwell Biotech (GWLL) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with -$21565.0 as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Other Gross PP&E Adjustments changed N/A year-over-year to -$21565.0, compared with a TTM value of -$21565.0 through Mar 2024, changed N/A, and an annual FY2023 reading of -$23665.0, up 10.18% over the prior year.
- Other Gross PP&E Adjustments was -$21565.0 for Q1 2024 at Goldenwell Biotech, up from -$23665.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$21565.0 in Q1 2024 and bottomed at -$63561.0 in Q1 2021.
- Average Other Gross PP&E Adjustments over 4 years is -$40254.0, with a median of -$38558.5 recorded in 2022.
- The sharpest move saw Other Gross PP&E Adjustments surged 45.96% in 2022, then rose 10.18% in 2023.
- Year by year, Other Gross PP&E Adjustments stood at -$48752.0 in 2021, then surged by 45.96% to -$26346.0 in 2022, then increased by 10.18% to -$23665.0 in 2023, then grew by 8.87% to -$21565.0 in 2024.
- Business Quant data shows Other Gross PP&E Adjustments for GWLL at -$21565.0 in Q1 2024, -$23665.0 in Q4 2023, and -$26346.0 in Q4 2022.